Matusiewicz Alexis K, Melbostad Heidi S, Heil Sarah H
Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychiatry, University of Vermont, Burlington, VT, USA.
Vermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Department of Psychological Science, University of Vermont, Burlington, VT, USA.
Contraception. 2017 Nov;96(5):365-369. doi: 10.1016/j.contraception.2017.07.167. Epub 2017 Aug 2.
To assess interest in, concerns about and knowledge of long-acting reversible contraceptives (LARC) among women in medication-assisted treatment (MAT) for opioid use disorder who were at risk for unintended pregnancy.
Women in MAT completed a survey on contraceptive use, attitudes and knowledge, including LARC methods, as part of eligibility screening for an ongoing trial evaluating family planning interventions for this population.
Eighty-three women at risk for unintended pregnancy completed the survey, and a subset of 51 completed supplemental questions about implants. All participants had heard of IUDs and 75/83 (90%) had heard of implants, but only 34/83 (41%) and 14/51 (27%) reported being likely to use IUDs and implants, respectively. Thirty-five women reported they were unlikely to use IUDs, with 29/35 (83%) citing unspecified "other reasons" for this position and 24/35 (69%) endorsing concerns about side effects. Seventeen women reported they were unlikely to use implants, with 8/17 (47%) citing "other reasons" and 9/17 (53%) and 10/17 (59%) reporting concerns about insertion and removal, respectively. Participants reported they knew "a little" about LARCs, but only their knowledge of implants was limited. Only 50/83 (60%) participants were aware of the superior effectiveness of IUDs and 26/51 (51%) were aware of the superior effectiveness of implants relative to other reversible methods.
Participants reported relatively low interest in LARCs. Many women had unspecified reasons for not using LARCs. Participants also lacked information about LARC safety and effectiveness, especially with regard to implants.
Women in medication-assisted treatment for opioid use disorder are at high risk of unintended pregnancy, yet contraceptive use is low and use of less effective methods is common. Women in MAT may benefit from efforts to increase knowledge about implants and assuage concerns about their insertion and removal as well as more general efforts to improve knowledge about the relative efficacy of LARCs. Many women in MAT endorsed unspecified "other reasons" for not using LARCs, which should be explored further.
评估处于药物辅助治疗(MAT)中的阿片类物质使用障碍女性对长效可逆避孕方法(LARC)的兴趣、担忧及了解程度,这些女性存在意外怀孕风险。
作为一项正在进行的针对该人群的计划生育干预评估试验资格筛查的一部分,处于MAT中的女性完成了一项关于避孕使用、态度及知识的调查,包括LARC方法。
83名有意外怀孕风险的女性完成了调查,其中51名完成了关于宫内节育器(IUD)的补充问题。所有参与者都听说过宫内节育器,83人中有75人(90%)听说过宫内节育器,但分别只有83人中有34人(41%)和51人中有14人(27%)表示可能会使用宫内节育器和宫内节育器。35名女性表示她们不太可能使用宫内节育器,其中35人中有29人(83%)称出于未指明的“其他原因”而持此立场,35人中有24人(69%)认可对副作用的担忧。17名女性表示她们不太可能使用宫内节育器,其中17人中有8人(47%)称“其他原因”,17人中有9人(53%)和17人中有10人(59%)分别表示担心放置和取出。参与者表示他们对长效可逆避孕方法了解“一点”,但仅对宫内节育器的了解有限。83名参与者中只有50人(60%)知道宫内节育器的避孕效果更好,51名参与者中只有26人(51%)知道宫内节育器相对于其他可逆避孕方法的避孕效果更好。
参与者对长效可逆避孕方法的兴趣相对较低。许多女性不使用长效可逆避孕方法的原因未明确说明。参与者也缺乏关于长效可逆避孕方法安全性和有效性的信息,尤其是关于宫内节育器的。
处于药物辅助治疗中的阿片类物质使用障碍女性意外怀孕风险高,但避孕措施使用率低且使用效果较差的方法很常见。处于MAT中的女性可能会受益于增加对宫内节育器的了解、缓解对其放置和取出的担忧以及更广泛地提高对长效可逆避孕方法相对有效性的认识的努力。许多处于MAT中的女性认可不使用长效可逆避孕方法的未指明“其他原因”,应进一步探讨。